Pulmonary microbiome and metabolome signatures associate with chemotherapy response in lung cancer patients
BackgroundLung cancer is a leading cause of cancer-related mortality worldwide, with chemotherapy response varying significantly among patients. Emerging evidence suggests that the pulmonary microbiota and metabolome may influence treatment outcomes, but their roles remain unclear.MethodsThis study...
Saved in:
| Main Authors: | Xuehang Jin, Lvjun Zhang, Chiqing Ying, Kailing Pan, Dan Zhu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Microbiology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2025.1604999/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gut microbiome and serum metabolome alterations in osteosarcoma patients
by: Chao Li, et al.
Published: (2025-07-01) -
Gut microbiota and metabolite features in NSCLC nude mouse models of subcutaneous tumor and leptomeningeal metastasis: a microbiome-metabolome combined analysis
by: Yang Du, et al.
Published: (2025-06-01) -
Adverse predictive value of ASPM on lung adenocarcinoma overall survival depended on chemotherapy status
by: Yan Zheng, et al.
Published: (2025-12-01) -
Major pathologic response and RAD51 predict survival in lung cancer patients receiving neoadjuvant chemotherapy
by: Apar Pataer, et al.
Published: (2018-06-01) -
The effects of a semen cuscutae flavonoids-based antidepressant treatment on microbiome and metabolome in mice
by: Qianfeng Shao, et al.
Published: (2025-05-01)